Ledger.Open graph →
SEC Form D · filed June 26, 2024

Elion Therapeutics, Inc

Offering
$83.8M
Sold
$25.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Martin Heidecker · Medford, MADirectorJim Flynn · New York, NYDirectorKieren Marr · Baltimore, MDExec · DirectorJonathan Leff · South San Francisco, CADirectorJim Flynn · New York, NYDirectorKieren Marr · Baltimore, MDExec · DirectorMartin Heidecker · Santa Monica, CADirectorJonathan Leff · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗